Stocks and InvestingStocks and Investing
Wed, August 17, 2022
Tue, August 16, 2022
Mon, August 15, 2022
Fri, August 12, 2022

Daniil Gataulin Maintained (ADVM) at Hold with Decreased Target to $25 on, Aug 12th, 2022


Published on 2024-10-27 22:38:50 - WOPRAI, Daniil Gataulin
  Print publication without navigation


Daniil Gataulin of Chardan Capital, Maintained "Adverum Biotechnologies, Inc." (ADVM) at Hold with Decreased Target from $30 to $25 on, Aug 12th, 2022.

Daniil has made no other calls on ADVM in the last 4 months.



There is 1 other peer that has a rating on ADVM. Out of the 1 peers that are also analyzing ADVM, 0 agree with Daniil's Rating of Hold.



This is the rating of the analyst that currently disagrees with Daniil


  • Joon Lee of "Truist Securities" Upgraded from Hold to Strong Buy and Increased Target to $40 on, Thursday, July 7th, 2022